MOUNTAIN VIEW, Calif. – AliveCor has received clearance from the U.S. Food and Drug Administration for the KardiaBand in the U.S., allowing Apple Watch users to capture their electrocardiogram anytime, anywhere in order to quickly detect normal sinus heart rhythms and atrial fibrillation. The first FDA-cleared medical device accessory for Apple Watch, KardiaBand can record an EKG in 30 seconds with just a touch of its integrated sensor. Results from the Kardia App are displayed on the face of Apple Watch. The company also introduced SmartRhythm, a new feature within the Kardia app for Apple Watch, that uses artificial intelligence in concert with inputs from Apple Watch’s heart rate and activity sensors to continuously evaluate the correlation between heart activity and physical activity. When SmartRhythm detects that heart rate and activity are out of sync, the device notifies users to capture an EKG with KardiaBand, or with KardiaMobile, AliveCor’s portable EKG reader. “KardiaBand paired with SmartRhythm technology will be life-changing for people who are serious about heart health,” said Vic Gundotra, CEO of AliveCor, said in a statement.
You are here: / / FDA clears KardiaBand as first medical device accessory for Apple Watch